TEC13-Advanced Surgery
Advanced Therapies and Biomedical Technologies / IBS-TEC13 / Consolidated
Research group formed around the General Surgery and Digestive System Service of the HUVN of Granada, and the areas that comprise it: Coloproctological, Endocrinological, Esophagogastric and Bariatric Surgery, Hepatobiliopancreatic and Liver Transplantation, Abdominal Wall Surgery, Trauma Surgery and Emergencies, and Nursing Care in Surgery. In each of these areas, the research approach is focused on the evaluation of the health technologies in use, the new technologies that are to be implemented, and the health results obtained, without forgetting the translational approach, genomics and contact with basic sciences.
Research lines
- Non-coding RNAs as markers of response to radiochemotherapy in rectal cancer. IP: Raquel Conde Muíño. 2016-2018.
- Prospective analysis of quality of life in patients undergoing gastric bypass vs. vertical gastrectomy.
- Study of umbilical cord mesenchymal cells in rectal cancer. Researcher: Dr. Huertas Peña.
- Study of mesenchymal cells in a peritumoral environment in colon cancer. Researcher: Dr. Huertas Peña.
- Impact of the dissemination of circulating tumor cells during pancreaticoduodenectomy on the appearance of metastasis and survival in patients with pancreatic and periampullary tumors. Multicenter clinical trial: led from the Virgen del Rocío University Hospital. IP: Dr. Javier Padillo. IC: Dr. Trinidad Villegas Herrera.
- Preoperative preparation with pneumoperitoneum and / or botulinum toxin for the surgery of giant hernias.
- Lugol's solution in patients scheduled for thyroidectomy for Graves-Basedow disease: LIGRADIS clinical trial comparing efficacy and safety of its administration versus direct surgery without said preparation. National multicenter study (18 hospitals) coordinated from our center and the Hospital de la Princesa de Madrid
MARIO SERRADILLA MARTIN
CARMEN ACOSTA GALLARDO
NATALIA ZAMBUDIO CARROL
MONICA MOGOLLON GONZALEZ
MARIA TRINIDAD VILLEGAS HERRERA
MARIA CARMEN PEREZ DURAN
ALBERTO CARRILLO ACOSTA
ALBA MARIA SANCHEZ ARCO
MARTA SANTIDRIAN ZURBANO
RAFAEL REJÓN LOPEZ
JENNIFER TRIGUERO-CABRERA
MOHAMED HASSIN CHAIRI
MARTA FERNANDEZ BAEZA
JOSE LUIS DIEZ VIGIL
ALEJANDRO JOSE PEREZ ALONSO
JESUS DAMIAN TURIÑO LUQUE
RACHEL COUNT MUINO
ALFONSO MANSILLA ROSELLO
NURIA MUÑOZ PEREZ
JESUS MARIA VILLAR DEL MORAL
Preoperative pneumoperitoneum in the surgical preparation of complex events
HISPANIC-AMERICAN JOURNAL OF HERNIA, 2023;
Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway as Survival Biomarkers in Colorectal Cancer
CANCER, 2023;
FI: 5,2; Q2
Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study
LANGENBECKS ARCHIVES OF SURGERY, 2023;
FI: 2,3; Q2
Impact of routine preoperative 18FDG PET/CT on the surgical management of primary colorectal cancer
JOURNAL OF SURGICAL ONCOLOGY, 2023;
FI: 2,5; Q4
Liver Transplant and Incisional Hernia: What Do We Know and What Can We Improve
TRANSPLANTATION PROCEEDINGS, 2023;
FI: 0,9; Q4
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
AMERICAN JOURNAL OF TRANSPLANTATION, 2022;
FI: 9,369; D1
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
AMERICAN JOURNAL OF TRANSPLANTATION, 2022;
FI: 9,369; D1
ASO Visual Abstract: Long-Term Outcomes of Perioperative versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases-An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk Scoring
ANNALS OF SURGICAL ONCOLOGY, 2022;
FI: 4,339; Q2
Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring
ANNALS OF SURGICAL ONCOLOGY, 2022;
FI: 4,339; Q2
Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options
UPDATES IN SURGERY, 2022;
FI: 2,692; Q2
Efficacy and safety of preoperative preparation with Lugol's iodine solution in euthyroid patients with Graves' disease (LIGRADIS Trial): Study protocol for a multicenter randomized trial
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021;
Adrenalectomy for incidental and symptomatic phaeochromocytoma: retrospective multicenter study based on the Eurocrine (R) database
BRITISH JOURNAL OF SURGERY, 2021;
FI: 6,939; D1
Complications after medullary thyroid carcinoma surgery: multicenter study of the SQRTPA and EUROCRINE (R) databases
BRITISH JOURNAL OF SURGERY, 2021;
FI: 6,939; D1
Development and validation of a new model for predicting hypocalcaemia after total thyroidectomy: the NuGra model
LANGENBECKS ARCHIVES OF SURGERY, 2021;
FI: 3,445; Q2
Giant pelvic teratoma
ESPANOL SURGERY, 2021;
FI: 1,653; Q3
Prophylaxis of venous thromboembolism in general surgery in Spain. Analysis of a national survey
ESPANOL SURGERY, 2020;
FI: 1,323; Q3
Cholangiocarcinoma: 10-year survival after liver transplantation. A case report.
TRANSPLANTATION PROCEEDINGS, 2020;
FI: 0,784; Q4
Eight Years of Extracorporeal Membrane Oxygenation in Liver Transplantation: Our Experience
TRANSPLANTATION PROCEEDINGS, 2020;
FI: 0,784; Q4
How Can We Improve the Selection of Patients Awaiting Liver Retransplantation?
TRANSPLANTATION PROCEEDINGS, 2020;
FI: 0,784; Q4
Liver Retransplantation: The Changing Scenario in a Tertiary Medical Center
TRANSPLANTATION PROCEEDINGS, 2020;
FI: 0,784; Q4
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
Journal of Hepatology, 2019;
FI: 18,946; D1
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation
Journal of Hepatology, 2019;
FI: 18,946; D1
Reply to: “ormothermic regional infusion – What is the benefit?”
Journal of Hepatology, 2019;
FI: 18,946; D1
A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain
ESPANOL SURGERY, 2019;
FI: 0,835; Q4
Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc
ONCOTARGET, 2017;
FI: 5,168; Q1
Preventing parastomal hernias with systematic intraperitoneal specifically designed mesh
BMC SURGERY, 2017;
FI: 1,422; Q3
Influence of Body Mass Index on Venous Thrombotic Complications of Liver Transplants
TRANSPLANTATION PROCEEDINGS, 2016;
FI: 0,867; Q4
Predictive Biomarkers to chemoradiation in Locally Advanced Rectal Cancer
BIOMED RESEARCH INTERNATIONAL, 2015;
FI: 1,579; Q3
Complications Associated With Liver Transplantation in Recipients With Body Mass Index> 35 kg / m (2): Would It Be a Poor Prognosis Predictive Factor?
TRANSPLANTATION PROCEEDINGS, 2015;
FI: 0,982; Q3
Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital
TRANSPLANTATION PROCEEDINGS, 2015;
FI: 0,982; Q3
Influence of Waiting List in Recurrence Disease of Hepatocellular Carcinoma
TRANSPLANTATION PROCEEDINGS, 2015;
FI: 0,982; Q3
Role of Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Within the Milan Criteria
TRANSPLANTATION PROCEEDINGS, 2015;
FI: 0,982; Q3
FAECP_2016_CONDE RAQUEL CONDE - Non-coding RNAs as markers of response to radiochemotherapy in rectal cancer.
Funder: ASOCIACION ESPAÑOLA DE COLOPROCTOLOGIA
File number: FAECP_2016_CONDE
Execution time: 18/11/2016 - 17/11/2018
PI: RAQUEL CONDE MUIÑO